Trial Profile
Comparison of melphalan-prednisone (MP) to MP plus thalidomide in the treatment of newly diagnosed very elderly patients (greater than 75 years) with multiple myeloma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 May 2009
Price :
$35
*
At a glance
- Drugs Melphalan (Primary) ; Prednisone (Primary) ; Thalidomide (Primary)
- Indications Multiple myeloma
- Focus Registrational; Therapeutic Use
- 10 May 2009 Results published in Journal of Clinical Oncology.
- 09 Dec 2007 Status change from in progress to completed.
- 12 Jun 2007 New trial record.